The significance of an elevated cobalamin concentration in the blood;De betekenis van een te hoge cobalamineconcentratie in het bloed

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 10, 2002, Pages 459-464

  Ermens, A A M ^a   Vlasveld, L Th ^a   Van Marion Kievit, J A ^a   Lensen, C J P A ^a   Lindemans, J ^a  

^a AMPHIA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; HAPTOCORRIN;

ACUTE HEPATITIS; CHRONIC MYELOID LEUKEMIA; DIAGNOSTIC VALUE; HEMATOLOGIC DISEASE; HYPEREOSINOPHILIC SYNDROME; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; POLYCYTHEMIA VERA; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

HEMATOLOGIC DISEASES; HUMANS; LEUKEMIA; LIVER DISEASES; TRANSCOBALAMINS; VITAMIN B 12;

EID: 0037045908     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Nutritional factors in the production and function of erythrocytes
2. Fysiologie en pathofysiologie van de 'intrinsic factor'-secretie en de cobalamine(vitamine B12)-absorptie
3. The cloning and characterization of the human transcobalamin II gene
4. Assignment of human transcobalamin II (TC2) to chromosome 22 using somatic cell hybrids and monosomic meningioma cells
5. I): Comparison to human intrinsic factor
6. Human gastric intrinsic factor: Characterization of cDNA and genomic clones and localization to human chromosome II
7. Cobalamin metabolism in chronic myelogeneous leukemia
8. Human plasma R-type vitamin B12-binding proteins. II. The role of transcobalamin I, transcobalamin III, and the normal granulocyte vitamin B12-binding protein in the plasma transport of vitamin B12
9. Congenital deficiency of human R-type binding proteins of cobalamin
10. Receptor distribution and the endothelial uptake of transcobalamin II in liver cell suspensions
11. Cobalamin forms and analogues in plasma and myeloid cells during chronic myelogenous leukaemia related to the clinical condition
12. Erythrocyte vitamin B12 activity in health, polycythemia, and in deficiency of vitamin B12 and folate
13. The transcobalamins in polycythemia vera
14. The distribution of endogenous cobalamin among cobalamin-binding proteins in the blood in normal and abnormal states
15. Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia
16. Cobalamin and cobalamin-binding proteins in plasma related to the clinical condition in chronic myelogenous leukemia
17. Serum transcobalamin in myeloid leukemia
18. Acute promyelocytic leukemia: A report of five cases with a comment on the diagnostic significance of serum vitamin B12 determination
19. Serum vitamin B12 content and unsaturated vitamin B12-binding capacity in myeloproliferative disease. Value in differential diagnosis and as indicators of disease activity
20. Vitamin B12 and vitamin B12 binding proteins in liver diseases
21. Methylmalonic acid concentration in serum not affected in hepatic disease
22. Total corrinoid, cobalamin (vitamin B12), and cobalamin analogue levels may be normal in serum despite cobalamin in liver depletion in patients with alcoholism
23. Cobalamin (vitamin B12) and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease
24. Elevated vitamin B12 in cystic fibrosis
25. Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma
26. Blood transcobalamin levels in malignant hepatoma
27. Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma
28. Transcobalamin I as a 'marker' for fibrolamellar hepatoma
29. Increased concentration of transcobalamin I in a patient with metastatic carcinoma of the breast
30. Extreme elevation of serum transcobalamin I in a patient with metastatic cancer
31. Serum vitamin B12 and transcobalamin abnormalities in patients with cancer
32. Elevation of indicators of cobalamin deficiency defined as cobalamin-induced reduction in increased serum methylmalonic acid
33. Clinical spectrum and diagnosis of cobalamin deficiency
34. Alcoholic cirrhosis and cobalamin metabolism
35. Reduction of hyperhomocysteinaemia in a patient with CML treated with hydroxycarbamid